Baird Medical Investment Holdings Limited
BDMD
$1.95
$0.052.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.60% | 6.81% | 17.74% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.60% | 6.81% | 17.74% | -- | -- |
| Cost of Revenue | 8.67% | 6.06% | 3.69% | -- | -- |
| Gross Profit | -5.20% | 6.91% | 19.92% | -- | -- |
| SG&A Expenses | 47.58% | 24.27% | 0.64% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.06% | 39.08% | 10.85% | -- | -- |
| Operating Income | -101.61% | -41.55% | 29.11% | -- | -- |
| Income Before Tax | -110.08% | -52.52% | 13.98% | -- | -- |
| Income Tax Expenses | -2.06% | -7.42% | -12.45% | -- | -- |
| Earnings from Continuing Operations | -123.71% | -58.89% | 18.20% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.62% | -26.57% | -28.88% | -- | -- |
| Net Income | -125.27% | -59.80% | 18.09% | -- | -- |
| EBIT | -101.61% | -41.55% | 29.11% | -- | -- |
| EBITDA | -93.93% | -38.01% | 27.79% | -- | -- |
| EPS Basic | -109.73% | -51.21% | 18.79% | -- | -- |
| Normalized Basic EPS | -98.39% | -46.09% | 14.95% | -- | -- |
| EPS Diluted | -110.19% | -51.12% | 19.62% | -- | -- |
| Normalized Diluted EPS | -98.80% | -46.54% | 14.47% | -- | -- |
| Average Basic Shares Outstanding | 1.97% | -3.06% | -7.55% | -- | -- |
| Average Diluted Shares Outstanding | 2.28% | -2.77% | -7.26% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |